NAPISTAR 1-01 - An International Phase I/II Trial Of The Novel NaPi2b Targeting ADC TUB-040 In Platinum-Resistant Ovarian Cancer (PROC) And Relapsed/Refractory Non Small Cell Lung Cancer (NSCLC) | Publicación